Vivani Medical, Inc.
NASDAQ:VANIMedical - Devices
+$0.02 today
- Market cap
- $94.71M
- Beta
- 3.29
- P/E (TTM)
- -3.5
- EPS (TTM)
- -$0.33
Volume 0.18M
Average 0.24M
VANI Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Vivani Medical, Inc.NASDAQ: VANI
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization growth accelerates
Q1 FY2026 depreciation & amortization of $130K rose 27.5% year over year, ahead of the +12.2% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 13.0% from the prior quarter. Over 3 fiscal years it compounded at +3.6% a year.
Context
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +27.5% holds above the trailing-twelve-month pace of +12.2%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 424K USD
- Year-over-year change
- +6.0%
- 4-year CAGR
- +5.3%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 424K | +6.0% |
| FY2024 | 2024-12-31 | 400K | +12.0% |
| FY2023 | 2023-12-31 | 357K | -6.3% |
| FY2022 | 2022-12-31 | 381K | +10.4% |
| FY2021 | 2021-12-31 | 345K | — |
Depreciation & Amortization vs competitors
How VANI compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +12.2% is the 4th highest of 8, against a peer median of -1.6%.
- Over three fiscal years its annual growth of +3.6% compares with a peer median of +1.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $4.52M USD | -1.6% | +1.2% | 4.3% | |
| LTM Mar 2026 | $2.45M USD | +69.9% | +60.5% | 3.4% | |
| LTM Mar 2026 | $1.55M USD | +59.1% | +29.4% | 10.1% | |
IMAImageneBio Inc | LTM Mar 2026 | $822K USD | +129.6% | +11.2% | — |
| LTM Mar 2026 | $452K USD | +12.2% | +3.6% | — | |
| LTM Mar 2026 | $121K USD | -27.5% | -67.8% | — | |
| LTM Mar 2026 | CA$103.77K CAD | -66.0% | -14.3% | — | |
| LTM Mar 2026 | $44K USD | -43.6% | -22.8% | 41.9% | |
| Peer median (excluding VANI) | — | -1.6% | +1.2% | 7.2% | |
Competitors are the stored peer set for VANI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 357K | 0 | 424K |
| Gross Profit | 0 | 0 | (357K) | 0 | (424K) |
| Gross Margin | — | — | — | — | — |
| Research & Development | 11M | 14.17M | 16.97M | 15.75M | 18.13M |
| Selling, General & Admin | 2.32M | 5.37M | 10M | 8.93M | 9.43M |
| Operating Expenses | 13.32M | 21.24M | 26.61M | 24.68M | 27.13M |
| Depreciation & Amortization | 345K | 381K | 357K | 400K | 424K |
| EBITDA | (12.43M) | (19.16M) | (25.3M) | (23.09M) | (26.19M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (13.32M) | (21.24M) | (26.97M) | (24.68M) | (27.56M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 550K | 7.35M | 1.31M | 1.19M | 947K |
| Income Before Tax | (12.77M) | (13.89M) | (25.65M) | (23.49M) | (26.61M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (12.77M) | (13.89M) | (25.65M) | (23.49M) | (26.61M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (0.33) | (0.17) | (0.50) | (0.43) | (0.43) |
| EPS (Diluted) | (0.33) | (0.17) | (0.50) | (0.43) | (0.43) |
| Weighted Avg Shares | 36.25M | 38.24M | 50.85M | 54.98M | 62.39M |
| Weighted Avg Shares (Diluted) | 36.25M | 38.24M | 50.85M | 54.98M | 62.39M |
Vivani Medical, Inc.
NASDAQ:VANI
Intrinsic Alpha fair value
Locked
Current Price
$1.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.